These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage. Pegoli M; Mandrekar J; Rabinstein AA; Lanzino G J Neurosurg; 2015 Feb; 122(2):414-8. PubMed ID: 25495745 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598 [TBL] [Abstract][Full Text] [Related]
5. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study. McGirt MJ; Garces Ambrossi GL; Huang J; Tamargo RJ J Neurosurg; 2009 May; 110(5):968-74. PubMed ID: 19199459 [TBL] [Abstract][Full Text] [Related]
6. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome. Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598 [TBL] [Abstract][Full Text] [Related]
7. Impact of basilar artery vasospasm on outcome in patients with severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Sviri GE; Newell DW; Lewis DH; Douville C; Ghodke B; Chowdhary M; Lam AM; Haynor D; Zaaroor M; Britz GW Stroke; 2006 Nov; 37(11):2738-43. PubMed ID: 17008630 [TBL] [Abstract][Full Text] [Related]
8. Current and future treatment considerations in the management of aneurysmal subarachnoid hemorrhage. Rhoney DH; McAllen K; Liu-DeRyke X J Pharm Pract; 2010 Oct; 23(5):408-24. PubMed ID: 21507846 [TBL] [Abstract][Full Text] [Related]
9. Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage. Daou BJ; Koduri S; Thompson BG; Chaudhary N; Pandey AS CNS Neurosci Ther; 2019 Oct; 25(10):1096-1112. PubMed ID: 31583833 [TBL] [Abstract][Full Text] [Related]
10. Origins of the Concept of Vasospasm. Macdonald RL Stroke; 2016 Jan; 47(1):e11-5. PubMed ID: 26337970 [No Abstract] [Full Text] [Related]
11. Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) and Risk of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Griessenauer CJ; Chua MH; Hanafy KA; Baffour YT; Chen R; LeBlanc RH; Patel AS; Salem M; Karumanchi SA; Xu D; Thadhani R; Ogilvy CS; Thomas AJ World Neurosurg; 2017 Dec; 108():84-89. PubMed ID: 28867315 [TBL] [Abstract][Full Text] [Related]
12. A Review of the Management of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Li K; Barras CD; Chandra RV; Kok HK; Maingard JT; Carter NS; Russell JH; Lai L; Brooks M; Asadi H World Neurosurg; 2019 Jun; 126():513-527. PubMed ID: 30898740 [TBL] [Abstract][Full Text] [Related]
13. Methodological assessment of guidelines for the diagnosis and management of cerebral vasospasm using the AGREE-II tool. Tasiou A; Brotis AG; Tzerefos C; Lambrianou X; Fountas KN Neurosurg Focus; 2022 Mar; 52(3):E11. PubMed ID: 35231886 [TBL] [Abstract][Full Text] [Related]
14. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage. Dubinski D; Won SY; Konczalla J; Mersmann J; Geisen C; Herrmann E; Seifert V; Senft C World Neurosurg; 2017 Jan; 97():532-537. PubMed ID: 27777156 [TBL] [Abstract][Full Text] [Related]
15. Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Trimble JL; Kockler DR Ann Pharmacother; 2007 Dec; 41(12):2019-23. PubMed ID: 17986515 [TBL] [Abstract][Full Text] [Related]
16. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Koenig MA Continuum (Minneap Minn); 2012 Jun; 18(3):579-97. PubMed ID: 22810250 [TBL] [Abstract][Full Text] [Related]
17. The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Mao G; Gigliotti MJ; Esplin N; Sexton K Clin Neurol Neurosurg; 2021 Mar; 202():106546. PubMed ID: 33588359 [TBL] [Abstract][Full Text] [Related]
18. Predictors of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage with Asymptomatic Angiographic Vasospasm on Admission. Aldakkan A; Mansouri A; Jaja BN; Alotaibi NM; Macdonald RL; World Neurosurg; 2017 Jan; 97():199-204. PubMed ID: 27717776 [TBL] [Abstract][Full Text] [Related]
19. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Tseng MY; Czosnyka M; Richards H; Pickard JD; Kirkpatrick PJ Stroke; 2005 Aug; 36(8):1627-32. PubMed ID: 16049199 [TBL] [Abstract][Full Text] [Related]